Morgan Stanley Capital Partners has successfully closed its North Haven Capital Partners VIII fund at $3.2 billion, surpassing its initial target of $2.5 billion and reaching the third-party hard cap of $3.0 billion in under a year. The fund, which marks a 60% increase from its predecessor, attracted strong backing from both existing and new investors, including institutional investors and high-net-worth individuals across multiple continents. Fund VIII aims to invest in the U.S. middle market by partnering with founders and management teams, focusing on control investments in sectors such as consumer, business, healthcare, and industrial services. The fund has already deployed 17% of its capital into three companies, including American Restoration, FoodScience, and Thermogenics, leveraging Morgan Stanley's extensive resources and expertise to drive growth and value creation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.